EM-036

N/A

Report date: 2022/03/23 17:09:35

Base Information

Drug NameEM-036
Drug Alias NameEM-036
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsSerotonin 3 (5-HT3) receptor antagonistsNicotinic receptors antagonists
TargetsNicotinic receptorsSerotonin 3 (5-HT3) receptorGlutamate [NMDA] receptor
Therapy Area/IndicationsAutism Spectrum DisorderAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEumentis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEumentis Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutism Spectrum DisorderAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A